Lineage Cell Therapeutics, Inc. - COM (LCTX)

Q1 2022 13F Holders as of 3/31/2022

Type / Class
Equity / COM
Number of holders
100
Total Shares
72.8M
Shares change
-1.65M
Total reported value, excl. options
$112M
Value change
-$3.92M
Put/Call ratio
0.38
Number of buys
26
Number of sells
-55
Price
$1.54
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.